SCHEMBL3062610

SCHEMBL3062610

COc1ccccc1C(=O)N1CCc2cc(S(N)(=O)=O)c(OC)cc2C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
ALDH1A1 P00352 2/20 0.54
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA7 P43166 1/20 0.47
CA14 Q9ULX7 1/20 0.47
ACHE P22303 3/20 0.46
BACE1 P56817 1/20 0.46
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTT P42858 1/20 0.42
USP2 O75604 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TRIM24 O15164 1/20 0.40
PDE4B Q07343 1/20 0.40
P2RX3 P56373 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3061743 0.86 ALDH1A1 (0.59) CA2CA9ALDH1A1ACHEBACE1
SCHEMBL3046541 0.83 CA2 (0.78) CA2CA9ALDH1A1CA1CA7
SCHEMBL3051349 0.83 CA2 (0.63) CA2CA9ALDH1A1CA12CA1
SCHEMBL3052262 0.83 CA2 (0.60) CA2CA9ALDH1A1CA12CA1
SCHEMBL3048405 0.82 CA2 (0.58) CA2CA9ALDH1A1CA12CA1
SCHEMBL3055432 0.82 CA9 (0.61) CA2CA9ALDH1A1CA12CA1
SCHEMBL3062616 0.80 CA2 (0.56) CA2CA9CA12CA1CA7
SCHEMBL3049295 0.79 KDM4E (0.64) CA2CA9ALDH1A1CA12CA1
SCHEMBL3048205 0.78 ALDH1A1 (0.52) CA2CA9ALDH1A1MEN1KMT2A
SCHEMBL3052392 0.78 TSHR (0.47) CA2CA9LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US claimed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
EP-2155192-B1 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS STERIX LTD (GB) 2016-09-28 EP disclosed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC CA2 1077/4885CA9 1002/4885ALDH1A1 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.